- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT03953352
Evaluation of the Automatic Deformable Recontouring on the Daily MVCT for Head and Neck Cancer Adaptive Radiotherapy (GIRAFE)
This trial is a prospective, monocentric study aiming to evaluate an adaptive radiotherapy method (automatic deformable recontouring on the daily MVCT (MegaVoltage Computerized Tomography)) using the Precise ART™ software in patients with head and neck cancer.
Patients will receive helical intensity-modulated radiotherapy (IMRT) according to the standard recommendations (35 fractions during 7 weeks). Radiotherapy will include daily repositioning MVCT.
For the study, patients will undergo 4 intermediate re-planning CT-scan (without injection of intravenous contrast agent) at week 3, week 4, week 5 and week 6 of treatment.
3 recontouring modalities will be evaluated for the study:
- Manuel recontouring (standard method)
- Precise ART™ deformed contours
- Precise RTX™ deformed contours
The total duration of the study for each patient will be 7 weeks.
연구 개요
연구 유형
단계
- 해당 없음
연락처 및 위치
연구 장소
-
-
-
Toulouse, 프랑스
- Institut Universitaire Du Cancer Toulouse - Oncopole (Iuct-O)
-
-
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
설명
Inclusion Criteria:
- Age ≥ 18 years old
- Patient with histologically proven locally advanced head and neck cancer (Oropharynx, hypopharynx, larynx, nasopharynx, oral cavity, sinuses, nasal cavities, ethmoid sinus, cavum, salivary glands)
- Cancer with nodal involvement (at least T3 or involved node >2 cm)
- Eastern Cooperative Oncology Group performance status 0 or 1
- No previous curative treatment for head and neck cancer (surgery and/or radiotherapy and/or chemotherapy)
- Indication of exclusive radiotherapy (+/- chemotherapy) validated in multidisciplinary meeting
- Patient affiliated to the french social security system.
- Patient must provide written informed consent prior to inclusion in the study and any study-specific procedure.
Exclusion Criteria:
- Patient with metastatic cancer
- Eastern Cooperative Oncology Group performance status ≥ 2 (due to comorbidities)
- Patient with recurrent disease
- Patient who required urgent surgical treatment
- Contraindications to radiotherapy
- History of cancer within 5 years
- Patient already included in another therapeutic trial
- Pregnant or breastfeeding women
- Any psychological, familial, geographical or sociological condition potentially preventing the medical follow-up and/or study procedures
- Patient protected by law
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 다른
- 할당: 해당 없음
- 중재 모델: 단일 그룹 할당
- 마스킹: 없음(오픈 라벨)
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
---|---|
다른: Radiotherapy treatment
|
Helical intensity-modulated radiotherapy (35 fractions, 5 fractions per week) will be administered during 7 weeks: 2 Gy per fraction on tumor and 1.6 Gy per fraction on bilateral lymph node areas.
|
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
기간 |
---|---|
Rate of patients with Dice Similarity Coefficient (DSC) of the volumes of left and right parotid gland superior to 0.85 (DSC > 0.85)
기간: 7 weeks for each patient
|
7 weeks for each patient
|
2차 결과 측정
결과 측정 |
기간 |
---|---|
Rate of patients with DSC > 0.85 for other organs at risk (oral cavity, medullar canal, mandible,brain stem, larynx)
기간: 7 weeks for each patient
|
7 weeks for each patient
|
Rate of patients with DSC > 0.85 for target volumes (clinical target volume, gross target volume, planning target volume)
기간: 7 weeks for each patient
|
7 weeks for each patient
|
Time saving defined by the difference between standard recontouring time (manuel recontouring) and experimental recontouring time (Precise ART™ or Precise RTX™)
기간: 7 weeks for each patient
|
7 weeks for each patient
|
공동 작업자 및 조사자
연구 기록 날짜
연구 주요 날짜
연구 시작 (예상)
기본 완료 (예상)
연구 완료 (예상)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .
Helical intensity-modulated radiotherapy (IMRT)에 대한 임상 시험
-
Centre hospitalier de l'Université de Montréal...종료됨